Company Overview and News

14
"The Past Week: Painful, But Nowhere Near The Same Week 10 Years Ago

3h seekingalpha
However, it was nothing like what investors experienced on the very same week 10 years ago.
WFCNP RF KEY STI-A CIT BBT WFC C STI

14
The Past Week: Painful, But Nothing Anywhere Like The Same Week 10 Years Ago

4h seekingalpha
However, it was nothing like what investors experienced on the very same week 10 years ago.
WFCNP RF KEY STI-A CIT BBT WFC C STI

3
Rough Week For Real Estate As Volatility Returns

2018-10-13 seekingalpha
Homebuilders and REITs dipped for the third consecutive week as financial volatility returned with a vengeance. The S&P 500 dipped more than 5%, while homebuilders dipped 6%.
BBT USB PLD KEY

62
Bank Stock Roundup: Stocks Plunge on Trade War Worries, JPMorgan & Citi in Focus

2018-10-12 zacks
Over the past five trading sessions, major market indexes witnessed significant sell-off (majority occurring over the last two days), and major banks were not untouched. Concerns related to the impact of rising interest rates and trade war on the global economy as well as increasing yields on government bonds were the primary reasons for the decline in stock market. President Trump’s comments criticizing the Federal Reserve for persistently increasing the interest rates added fuel to fire.
WFCNP DB KEY BAC USB WFC DUKH BAC C CMA DUK

1
KeyCorp (KEY) Q3 Earnings Preview: What's Shaping Up?

2018-10-11 zacks
KeyCorp (KEY - Free Report) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2018. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.
KEY

22
10 Financial Stocks to Consider Before They’re No Longer Worth It

2018-10-05 investorplace - 1
Rising interest rates generally prove a boon for financial stocks, but if turmoil in Turkey turns into an outright contagion that infects the rest of the world, it’s unlikely any sector would be spared regardless of the backdrop. Never mind the fact that the wrong headline can pull the rug out from underneath the market without any warning.
DFS SQ C RF DTK PYPL KEY GS VIRT AMTD ICE ENVA EBAY

40
3 Big Stock Charts for Wednesday: KeyCorp, Copart and Akamai Technologies

2018-10-03 investorplace - 1
Stocks may have gotten Tuesday’s trading started on the right foot, but they certainly didn’t end them that way. Although the S&P 500 managed to claw back some of what was at one point an intraday loss of 0.17%, the 0.04% loss the index ended up logging yesterday was still not a gain — and the market needed a decisive gain.
GE GEC CPRT GNE AMD INTC KEY AKAM

48
KeyCorp (KEY) Poised for Revenue Growth Despite Higher Costs

2018-10-02 zacks
KeyCorp (KEY - Free Report) remains well positioned for top-line growth, supported by continued rise in loans and deposits along with higher interest rates. Given a solid capital position, the company is expected to continue enhancing shareholder value through efficient capital deployment activities. However, KeyCorp’s significant exposure to risky loan portfolios might curb its growth in the near term.
BAC BBT BAC CMA KEY CMPWW

1
KeyCorp: Time For A Pause

2018-09-26 seekingalpha
KeyCorp has been our high conviction idea into 2017 among the regional lenders and has performed well for the past couple of years.
KEY

1
KeyCorp: Now Is A Great Time To Start Looking At This Regional Bank

2018-09-26 seekingalpha
However, KeyCorp is in a great position to benefit from an improving backdrop (i.e., rising rate environment, less-burdensome regulations, and a stronger economy).
KEY

4
Thinking About Investing In Canadian Midstream, Eh?

2018-09-26 seekingalpha - 1
Over time, the US and Canadian energy markets have become more integrated. Energy trade and cross-border asset ownership are just some examples of this interconnectedness. Enbridge's (NYSE:ENB) simplification plan, which includes acquiring its sponsored MLPs Spectra Energy Partners (NYSE:SEP) and Enbridge Energy Partners (NYSE:EEP), is a company-level example of the overlap between US and Canadian midstream.
TRP DTK ENB ALJ KEY IPL SEP ENB ALDW KEY TRP EEP PBA IPPLF

135
Tracking David Tepper's Appaloosa Management Portfolio - Q2 2018 Update

2018-09-03 seekingalpha - 10
This article is part of a series that provides an ongoing analysis of the changes made to David Tepper’s 13F portfolio on a quarterly basis. It is based on Appaloosa Management’s regulatory 13F Form filed on 08/14/2018. Please visit our Tracking David Tepper’s Appaloosa Management Portfolio series to get an idea of his investment philosophy and our previous update for the fund’s moves during Q1 2018.
PCG LRCX SYMC KMT CQP CNC VST XOP KEY NRGEO CFIN WPZ BSX CIWV HCA SYK AABA AMAT WMB SUM BTUUQ VNTR BAC TMUSP LNG TMUS OC NRG ALL BABA ETP CZR GOOGL WMIH TERP WFCNP MGM FB PAH AY TMO WDC NVDA GOOG BAC HUN AGN UBS WFC WMIHP GJT XPO CFG BTU ALLY MU VSTE URI DG ULSGF

1
7 Reasons to Invest in Comerica Incorporated (CMA) Right Now

2018-08-21 zacks
In the Q2 earnings season, the Finance sector turned out to be one of the best performers. Particularly, benefits from a stabilizing economy and improving interest-rate scenario have well positioned the banking industry. Moreover, lower commercial tax rate are likely to boost banks’ profitability further. In addition, relieving banks from some of the stringent requirements of the Dodd-Frank Act has made the companies optimistic of future earnings growth and raised investors’ sentiments as well.
STI CMA KEY CMPWW

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to KEY / KeyCorp on message board site Silicon Investor.

Keysight Technologies Keysight Technologies Keysight Technologies Hockey :: Stanley Cup Playoffs Hockey :: Stanley Cup Playoffs Hockey :: Stanley Cup Playoffs
Buckeyu0027s Bottom Bounce Short Term Picks (CDN ONLY) Buckeyu0027s Bottom Bounce Short Term Picks (CDN ONLY) Buckeyu0027s Bottom Bounce Short Term Picks (CDN ONLY) HAWKEYE Gold Grants 985,000 Incentive Stock Options HAWKEYE Gold Grants 985,000 Incentive Stock Options HAWKEYE Gold Grants 985,000 Incentive Stock Options
HAWKEYE Gold Grants 985,000 Incentive Stock Options HAWKEYE Gold Grants 985,000 Incentive Stock Options HAWKEYE Gold Grants 985,000 Incentive Stock Options HAWKEYE GOLD PURCHASE TOP PROPERTY - YUKON HAWKEYE GOLD PURCHASE TOP PROPERTY - YUKON HAWKEYE GOLD PURCHASE TOP PROPERTY - YUKON
HAWKEYE GOLD. TSX SYMBOL - HGO HAWKEYE GOLD. TSX SYMBOL - HGO HAWKEYE GOLD. TSX SYMBOL - HGO News Links and Chart Links KEY POSTS News Links and Chart Links KEY POSTS News Links and Chart Links KEY POSTS
Buckeye Cellulose - BKI Low PE- High Growth Buckeye Cellulose - BKI Low PE- High Growth Buckeye Cellulose - BKI Low PE- High Growth The Donkeyu0027s Inn The Donkeyu0027s Inn The Donkeyu0027s Inn
CUSIP: 493267108